TY - JOUR
T1 - Circulating exosomes from brain death and cardiac death donors have distinct molecular and immunologic properties
T2 - A pilot study
AU - Ravichandran, Ranjithkumar
AU - Itabashi, Yoshihiro
AU - Zhou, Fangyu
AU - Lin, Yiing
AU - Mohanakumar, Thalachallour
AU - Chapman, William C.
N1 - Publisher Copyright:
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2023/10
Y1 - 2023/10
N2 - Background and aims: Comparison of donation after brain death (DBD) and donation after cardiac death (DCD) lung tissue before transplantation have demonstrated activation of pro-inflammatory cytokine pathway in DBD donors. The molecular and immunological properties of circulating exosomes from DBD and DCD donors were not previously described. Methods: : We collected plasma from 18 deceased donors (12 DBD and six DCD). Cytokines were analyzed by 30-Plex luminex Panels. Exosomes were analyzed for liver self-antigen (SAg), Transcription Factors and HLA class II (HLA-DR/DQ) using western blot. C57BL/6 animals were immunized with isolated exosomes to determine strength and magnitude of immune responses. Interferon (IFN)-γ and tumor necrosis factor-α producing cells were quantified by ELISPOT, specific antibodies to HLA class II antigens were measured by ELISA. Results: We demonstrate increased plasma levels of IFNγ, EGF, EOTAXIN, IP-10, MCP-1, RANTES, MIP-β, VEGF, and interleukins – 6/8 in DBD plasma versus DCD. MiRNA isolated from exosome of DBD donors demonstrated significant increase in miR-421, which has been reported to correlate with higher level of Interleukin-6. Higher levels of liver SAg Collagen III (p =.008), pro-inflammatory transcription factors (NF-κB, p <.05; HIF1α, p =.021), CIITA (p =.011), and HLA class II (HLA-DR, p =.0003 and HLA-DQ, p =.013) were detected in exosomes from DBD versus DCD plasma. The circulating exosomes isolated from DBD donors were immunogenic in mice and led to the development of Abs to HLA-DR/DQ. Conclusions: This study provides potential new mechanisms by which DBD organs release exosomes that can activate immune pathways leading to cytokine release and allo-immune response.
AB - Background and aims: Comparison of donation after brain death (DBD) and donation after cardiac death (DCD) lung tissue before transplantation have demonstrated activation of pro-inflammatory cytokine pathway in DBD donors. The molecular and immunological properties of circulating exosomes from DBD and DCD donors were not previously described. Methods: : We collected plasma from 18 deceased donors (12 DBD and six DCD). Cytokines were analyzed by 30-Plex luminex Panels. Exosomes were analyzed for liver self-antigen (SAg), Transcription Factors and HLA class II (HLA-DR/DQ) using western blot. C57BL/6 animals were immunized with isolated exosomes to determine strength and magnitude of immune responses. Interferon (IFN)-γ and tumor necrosis factor-α producing cells were quantified by ELISPOT, specific antibodies to HLA class II antigens were measured by ELISA. Results: We demonstrate increased plasma levels of IFNγ, EGF, EOTAXIN, IP-10, MCP-1, RANTES, MIP-β, VEGF, and interleukins – 6/8 in DBD plasma versus DCD. MiRNA isolated from exosome of DBD donors demonstrated significant increase in miR-421, which has been reported to correlate with higher level of Interleukin-6. Higher levels of liver SAg Collagen III (p =.008), pro-inflammatory transcription factors (NF-κB, p <.05; HIF1α, p =.021), CIITA (p =.011), and HLA class II (HLA-DR, p =.0003 and HLA-DQ, p =.013) were detected in exosomes from DBD versus DCD plasma. The circulating exosomes isolated from DBD donors were immunogenic in mice and led to the development of Abs to HLA-DR/DQ. Conclusions: This study provides potential new mechanisms by which DBD organs release exosomes that can activate immune pathways leading to cytokine release and allo-immune response.
KW - HLA class II
KW - cytokines
KW - donation after brain death
KW - donation after cardiac death
KW - exosomes
KW - interleukin-6
KW - micro RNA
UR - http://www.scopus.com/inward/record.url?scp=85164742300&partnerID=8YFLogxK
U2 - 10.1111/ctr.15067
DO - 10.1111/ctr.15067
M3 - Article
C2 - 37428019
AN - SCOPUS:85164742300
SN - 0902-0063
VL - 37
JO - Clinical Transplantation
JF - Clinical Transplantation
IS - 10
M1 - e15067
ER -